PUT/ABBOTT LABORATORIES/100/0.1/21.06.24 Stock

Warrant

DE000GQ2SBR3

Real-time BOERSE MUENCHEN 10:27:12 2024-06-19 EDT
0.008 EUR -11.11% Intraday chart for PUT/ABBOTT LABORATORIES/100/0.1/21.06.24
Current month-90.91%
1 month-84.75%
Date Price Change
24-06-19 0.008 -11.11%
24-06-18 0.009 -47.06%
24-06-17 0.017 -41.38%
24-06-14 0.029 +3.57%
24-06-13 0.028 +47.37%

Real-time BOERSE MUENCHEN

Last update June 19, 2024 at 10:27 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GQ2SBR
ISINDE000GQ2SBR3
Date issued 2023-08-21
Strike 100 $
Maturity 2024-06-21 (2 Days)
Parity 10 : 1
Emission price 0.52
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.177
Lowest since issue 0.005
Spread 0.02
Spread %80.00%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104 USD
Average target price
125.4 USD
Spread / Average Target
+20.56%
Consensus